Revised Integrated Filing (Financial) for Quarter and Year ended on 31st March, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vaxfab Enterprises (formerly Ellora Trading) filed its revised integrated financial results for FY25. Revenue from operations surged to ₹5,867.10 lakhs from ₹914.39 lakhs in FY24, a jump of roughly 542%. The company swung back to profit, posting a Profit After Tax of ₹58.42 lakhs compared to a loss of ₹356.99 lakhs in the previous year, with basic EPS improving to ₹0.695 from a negative ₹4.250. Total assets expanded sharply to ₹11,225.28 lakhs, driven mainly by a massive inventory build-up (₹6,627.27 lakhs vs ₹52.21 lakhs) and higher trade receivables, while trade payables ballooned to ₹8,766.87 lakhs. Despite the turnaround on paper, operating cash flow remained deeply negative at ₹(601.02) lakhs. Statutory auditor SSRV & Associates issued an unmodified (clean) opinion on the results.
The headline numbers look strong with a return to profitability and explosive revenue growth, but the negative operating cash flow and sharp rise in inventory and trade payables suggest the company is funding its growth through stretched working capital rather than cash generation — something retail investors should watch closely.